When was Positron Precision founded?

Positron Precision was founded in 2019.

Where is Positron Precision located?

Positron Precision is headquartered in Zornheim, Germany.

How many employees does Positron Precision have?

As of Aug 31, 2026, the latest employee count at Positron Precision is 1.

Where does Positron Precision rank among its competitors?

Positron Precision ranks 2522nd amongst 2570 active competitors, of which 872 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Positron Precision?

Positron Precision's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Positron Precision - 2026 Company Profile & Competitors

Company Details

Developer of radiopharmaceuticals for positron emission tomography. It offers medical radioisotopes 68Ga, n.c.a. lutetium-177 (177Lu) and actinium-225 (225Ac) for diagnosis and targeted treatment of various cancer indications.

Website: positron-precision.com
Email ID: *****@positron-precision.com
Phone Number: +49 **********

Key Metrics

Founded Year

2019

Location

Zornheim, Germany

Stage

Acquired

Ranked

2522^nd among 2570 active competitors

Employee Count

1 as on Aug 31, 2026

Similar Companies

RayzeBio & 123 more

Exit Details

Acquired by ITM (Aug 18, 2022)

View Positron Precision's full profile

Positron Precision is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Positron Precision GmbH CIN: HRB232910 , Germany, Active	Apr 03, 2019	-	-

Positron Precision got acquired by ITM on Aug 18, 2022.

Click here to take a look at Positron Precision's acquisition in detail

Positron Precision has not raised any funding rounds yet.

Positron Precision's employee count trend

Positron Precision has 1 employees as of Aug 26. Here is Positron Precision's employee count trend over the years:

Employee count trend for Positron Precision

Uncover Positron Precision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Positron Precision include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Positron Precision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
6th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	72/100
7th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
8th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
9th	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Efung Capital & 5 others	71/100
10th	Tango Therapeutics 2017, Cambridge (United States), Public	Developer of drugs for the treatment of cancer	$165M	Boxer Capital, Casdin Capital & 8 others	71/100
2522nd	Positron Precision 2019, Zornheim (Germany), Acquired	Developer of radiopharmaceuticals for positron emission tomography	-	-	18/100